RGNX Q1 2026 Earnings WiderthanExpected Loss and Absent Revenue Weigh on Shares Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip SHIM Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement DTST Q1 2026 Earnings Narrower Loss Surprises Stock Under Pressure Cytokinetics Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Takes Center Stage The Lovesac Company LOVE Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Modestly